280 related articles for article (PubMed ID: 10942849)
1. Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex.
Zhang W; Perry KW; Wong DT; Potts BD; Bao J; Tollefson GD; Bymaster FP
Neuropsychopharmacology; 2000 Sep; 23(3):250-62. PubMed ID: 10942849
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute olanzapine after sustained fluoxetine on extracellular monoamine levels in the rat medial prefrontal cortex.
Amargós-Bosch M; Artigas F; Adell A
Eur J Pharmacol; 2005 Jun; 516(3):235-8. PubMed ID: 15967429
[TBL] [Abstract][Full Text] [Related]
3. Olanzapine increases in vivo dopamine and norepinephrine release in rat prefrontal cortex, nucleus accumbens and striatum.
Li XM; Perry KW; Wong DT; Bymaster FP
Psychopharmacology (Berl); 1998 Mar; 136(2):153-61. PubMed ID: 9551772
[TBL] [Abstract][Full Text] [Related]
4. Fluoxetine, but not other selective serotonin uptake inhibitors, increases norepinephrine and dopamine extracellular levels in prefrontal cortex.
Bymaster FP; Zhang W; Carter PA; Shaw J; Chernet E; Phebus L; Wong DT; Perry KW
Psychopharmacology (Berl); 2002 Apr; 160(4):353-61. PubMed ID: 11919662
[TBL] [Abstract][Full Text] [Related]
5. Effect of risperidone on the fluoxetine-induced changes in extracellular dopamine, serotonin and noradrenaline in the rat frontal cortex.
Kamińska K; Gołembiowska K; Rogóż Z
Pharmacol Rep; 2013; 65(5):1144-51. PubMed ID: 24399710
[TBL] [Abstract][Full Text] [Related]
6. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex.
Rollema H; Lu Y; Schmidt AW; Sprouse JS; Zorn SH
Biol Psychiatry; 2000 Aug; 48(3):229-37. PubMed ID: 10924666
[TBL] [Abstract][Full Text] [Related]
7. Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex.
Huang M; Ichiwaka J; Li Z; Dai J; Meltzer HY
Psychopharmacology (Berl); 2006 Apr; 185(3):274-81. PubMed ID: 16521036
[TBL] [Abstract][Full Text] [Related]
8. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats.
Li SX; Perry KW; Wong DT
Neuropharmacology; 2002 Feb; 42(2):181-90. PubMed ID: 11804614
[TBL] [Abstract][Full Text] [Related]
9. Effect of antipsychotic drugs on extracellular serotonin levels in rat medial prefrontal cortex and nucleus accumbens.
Ichikawa J; Kuroki T; Dai J; Meltzer HY
Eur J Pharmacol; 1998 Jun; 351(2):163-71. PubMed ID: 9686999
[TBL] [Abstract][Full Text] [Related]
10. 5-HT(2A) and D(2) receptor blockade increases cortical DA release via 5-HT(1A) receptor activation: a possible mechanism of atypical antipsychotic-induced cortical dopamine release.
Ichikawa J; Ishii H; Bonaccorso S; Fowler WL; O'Laughlin IA; Meltzer HY
J Neurochem; 2001 Mar; 76(5):1521-31. PubMed ID: 11238736
[TBL] [Abstract][Full Text] [Related]
11. In vivo biogenic amine efflux in medial prefrontal cortex with imipramine, fluoxetine, and fluvoxamine.
Jordan S; Kramer GL; Zukas PK; Moeller M; Petty F
Synapse; 1994 Dec; 18(4):294-7. PubMed ID: 7886621
[TBL] [Abstract][Full Text] [Related]
12. Dissociation of haloperidol, clozapine, and olanzapine effects on electrical activity of mesocortical dopamine neurons and dopamine release in the prefrontal cortex.
Gessa GL; Devoto P; Diana M; Flore G; Melis M; Pistis M
Neuropsychopharmacology; 2000 Jun; 22(6):642-9. PubMed ID: 10788763
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs induce similar effects on the release of dopamine and noradrenaline in the medial prefrontal cortex of the rat brain.
Westerink BH; de Boer P; de Vries JB; Kruse CG; Long SK
Eur J Pharmacol; 1998 Nov; 361(1):27-33. PubMed ID: 9851538
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
Beyer CE; Boikess S; Luo B; Dawson LA
J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
[TBL] [Abstract][Full Text] [Related]
15. R-fluoxetine increases extracellular DA, NE, as well as 5-HT in rat prefrontal cortex and hypothalamus: an in vivo microdialysis and receptor binding study.
Koch S; Perry KW; Nelson DL; Conway RG; Threlkeld PG; Bymaster FP
Neuropsychopharmacology; 2002 Dec; 27(6):949-59. PubMed ID: 12464452
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex.
Gronier BS; Rasmussen K
Neurosci Lett; 2003 Oct; 349(3):196-200. PubMed ID: 12951202
[TBL] [Abstract][Full Text] [Related]
17. Difference in the in vivo influence of serotonin1A autoreceptors on serotonin release in prefrontal cortex and dorsal hippocampus of the same rat treated with fluoxetine.
Li XM; Perry KW; Wong DT
Chin J Physiol; 1999 Jun; 42(2):53-9. PubMed ID: 10513599
[TBL] [Abstract][Full Text] [Related]
18. The combination of olanzapine and fluoxetine in mood disorders.
Shelton RC
Expert Opin Pharmacother; 2003 Jul; 4(7):1175-83. PubMed ID: 12831342
[TBL] [Abstract][Full Text] [Related]
19. BIMG 80, a novel potential antipsychotic drug: evidence for multireceptor actions and preferential release of dopamine in prefrontal cortex.
Volonté M; Monferini E; Cerutti M; Fodritto F; Borsini F
J Neurochem; 1997 Jul; 69(1):182-90. PubMed ID: 9202309
[TBL] [Abstract][Full Text] [Related]
20. Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.
Koch S; Perry KW; Bymaster FP
Neuropharmacology; 2004 Feb; 46(2):232-42. PubMed ID: 14680761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
